Next Article in Journal
Taste Receptor Activation in Tracheal Brush Cells by Denatonium Modulates ENaC Channels via Ca2+, cAMP and ACh
Previous Article in Journal
Retinal Vascular Physiology Biomarkers in a 5XFAD Mouse Model of Alzheimer’s Disease
Previous Article in Special Issue
Amelioration of Experimental Autoimmune Encephalomyelitis in Alzheimer’s Disease Mouse Models: A Potential Role for Aβ
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Cells
Volume 11
Issue 15
10.3390/cells11152415
cells-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Crosstalk between Biomolecular Condensates and Proteostasis

by
Emmanuel Amzallag
1,2 and
Eran Hornstein
1,2,*
1
Department of Molecular Neuroscience, Weizmann Institute of Science, Rehovot 7610001, Israel
2
Department of Molecular Genetics, Weizmann Institute of Science, Rehovot 7610001, Israel
*
Author to whom correspondence should be addressed.
Cells 2022, 11(15), 2415; https://doi.org/10.3390/cells11152415
Submission received: 30 May 2022 / Revised: 19 July 2022 / Accepted: 21 July 2022 / Published: 4 August 2022
(This article belongs to the Special Issue Cellular and Molecular Mechanisms of Neurodegenerative Diseases)
Browse Figures
Versions Notes

Abstract

:
Proper homeostasis of the proteome, referred to as proteostasis, is maintained by chaperone-dependent refolding of misfolded proteins and by protein degradation via the ubiquitin-proteasome system and the autophagic machinery. This review will discuss a crosstalk between biomolecular condensates and proteostasis, whereby the crowding of proteostasis factors into macromolecular assemblies is often established by phase separation of membraneless biomolecular condensates. Specifically, ubiquitin and other posttranslational modifications come into play as agents of phase separation, essential for the formation of condensates and for ubiquitin-proteasome system activity. Furthermore, an intriguing connection associates malfunction of the same pathways to the accumulation of misfolded and ubiquitinated proteins in aberrant condensates, the formation of protein aggregates, and finally, to the pathogenesis of neurodegenerative diseases. The crosstalk between biomolecular condensates and proteostasis is an emerging theme in cellular and disease biology and further studies will focus on delineating specific molecular pathways involved in the pathogenesis of amyotrophic lateral sclerosis (ALS) and other neurodegenerative diseases.

1. Crosstalk between Biomolecular Condensates and Proteostasis

Proteostasis is the term given to the cellular systems, which maintain the proteome in a functional state. Proteostasis relies on the activity of chaperones that mediate protein conformational refolding and repair and on the protein degradation machinery, comprised of the ubiquitin-proteasome system (UPS) and autophagy. Cellular stress and aging both cause a decrease in proteostasis capacity which contributes to the pathogenesis of neurodegenerative diseases associated with protein aggregation [1,2]. Both intrinsic properties of a protein’s primary sequence and its cellular abundance are associated with its aggregation propensity. A subset of the proteome has been discovered to exhibit a high expression level relative to solubility [3,4,5], and these proteins were found to associate with insoluble inclusions in a range of neurodegenerative diseases, including Alzheimer’s amyloid plaques, Lewy bodies, and ALS inclusions [3,4]. These so-called supersaturated proteins require constant activity of proteostasis machinery to maintain a soluble, non-aggregated state [6,7,8]. Thus the joint activity of the cell’s proteostatic systems keeps the levels of misfolded proteins sufficiently low to prevent the formation of cytotoxic protein aggregates [9,10].
Biomolecular condensates are macromolecular assemblies that are not encapsulated by a phospholipid bilayer and are hence also referred to as membraneless organelles. Condensates enable the compartmentalization and crowding of defined biomolecules that promote the activity of specific enzymatic processes. Condensation obeys basic biophysical principles of liquid–liquid phase separation (LLPS) of the biomolecules inside the condensate from the surrounding liquid, often cytoplasm or nucleoplasm [11,12,13]. Multivalent interactions between the biomolecules are key to phase separation. Valency in this context refers to a property which describes the number of binding sites within a molecule to which other molecules may attach. Multivalent proteins drive phase separation by interacting with multiple binding partners, leading to the formation of membraneless condensates [12]. The regulation of multivalent interactions and their specificity establishes particular compositions in defined condensates, recruiting some biomolecules and rejecting others.
In this review, we describe the emerging crosstalk between biomolecular condensates and proteostasis, with implications to cellular and disease biology.

2. An Emerging Family of Ubiquitin Condensates

2.1. The Ubiquitin-Proteasome System

Ubiquitination is an endogenous post-translational protein-tagging system, whereby ubiquitinated proteins are marked for degradation by the proteasome, establishing the ubiquitin-proteasome system (UPS) [14,15]. In addition to proteasomal degradation, ubiquitinated proteins may also be directed to degradation via the autophagic-lysosomal pathway [14,16]. Mechanistically, successive activity of ubiquitin-activating and -conjugating enzymes (E1, E2, and E3 families) transfer ubiquitin to lysine residues on target proteins. Proteins destined for degradation are polyubiquitinated with chains of ubiquitin, which are linked to each other via a specific lysine residue. Importantly, the different linkage types differ in their 3D conformation and are thus recognized by different sets of protein interactors, which direct the target proteins to different cellular processes [14,17]. Canonically, K48-linked polyubiquitin chains direct target proteins towards proteasomal degradation, while K63-linked polyubiquitin chains direct proteins to lysosomal degradation [14,17]. This is followed by engagement of specialized ubiquitin-binding shuttle proteins, including ubiquillins, RAD23B and p62, that bind ubiquitinated proteins and introduce them to the proteasome where they are broken down. However, only recently has it become apparent that the recruitment of UPS components to specialized membraneless condensates is an important biochemical feature of proper UPS function. Interestingly, recent studies have demonstrated the concept that polyubiquitin chains can function as multivalent molecules, which can drive either the assembly or the disassembly of condensates via interactions with various ubiquitin-binding proteins.

2.2. Ubiquitin-Binding Shuttle Proteins Drive Formation of Nuclear Condensates

Although the proteasome complex itself has ubiquitin-binding subunits, efficient delivery of ubiquitinated substrates to the proteasome is mediated by ubiquitin-binding shuttle proteins [18]. Such proteins are conserved across all eukaryotes and are characterized by containing at least one ubiquitin-associating (UBA) domain, which binds ubiquitin, and a ubiquitin-like (UBL) domain which binds proteasomes [18]. RAD23B is a typical ubiquitin-binding shuttle protein consisting of two UBA domains on its C-terminal and an N-terminal UBL domain. Other ubiquitin-binding shuttles exhibit additional structural characteristics which impact their function. The ubiquitin-binding protein p62 contains a single C-terminal UBA domain, however it exhibits oligomerization capacity dependent on its PB1 domain, which is crucial to its function in delivering ubiquitinated substrates to both the proteasome and to the autophagic machinery [19,20,21,22,23]. Ubiquilin 2 (UBQLN2) interacts with HSP70 via its ST1-like domains and contains an intrinsically disordered domain [24,25]. Thus, ubiquitin-binding shuttle proteins are crucial components of the cellular protein degradation machinery, which also have important distinct structural characteristics that regulate their function.
The cellular stress response initiates the assembly of transient condensates in the cytoplasm and the nucleus. Specific nuclear condensates, which contain active proteasomes and polyubiquitinated proteins, have been recently described [26]. These nuclear proteasomal condensates exhibit characteristics of liquid droplets, typical of phase-separated liquids, and depend on the presence of ubiquitinated proteins. The ubiquitin-binding shuttle protein RAD23B is pivotal in the formation of this type of nuclear proteasomal condensates. RAD23B condensation depends on its ability to bind ubiquitinated substrates via its two UBA domains [27]. Furthermore, condensates were found to include entire proteasomes, which are directly recruited by RAD23B via its N-terminal ubiquitin-like (UBL) domain, and to contain the E3 ligase E6-AP and the ubiquitin-binding chaperone VCP. RAD23B condensates may function in placing substrates, enzymes and the degradation machinery in proximity to each other, thus improving local concentrations and efficiency in response to cellular stress.
Clearance of RAD23B-positive nuclear proteasomal condensates is dependent on proteasomal and VCP activity, suggesting that degradation of ubiquitinated substrates within the condensates is required for cellular recovery from stress and is necessary for condensate dissolution [26]. Accordingly, inhibition of either proteasomal or VCP activities results in accumulation of ubiquitinated substrates within these nuclear condensates, illustrating that insufficient proteostasis can result in the formation of persistent protein aggregates. This is supported by the finding that a loss of RAD23B function results in agenesis of the corresponding nuclear condensates and in apoptosis. Thus, the formation of RAD23B-positive condensates safeguards cells against apoptosis and demonstrates that UPS activity in defined condensates is an adaptive means for cells to overcome proteotoxic stress.
Other nuclear or cytoplasmic condensates are formed around another ubiquitin-binding shuttle protein, p62/SQSTM1, along with ubiquitinated substrates [19]. p62 condensates form through phase separation, whereby valency increases once the UBA domain binds polyubiquitinated proteins (Figure 1). Several domains within p62 contribute to its condensation propensity, including the PB1 oligomerization domain, weak electrostatic interactions of p62′s intrinsically disordered domain, and the LC3-interacting region (LIR) [20,21,22]. The function of cytoplasmic p62 condensates is to initiate degradation of the ubiquitinated proteins inside autophagosomes [23,28,29]. In this context, p62 condensation together with ubiquitinated substrates function as a platform upon which the autophagosomal membrane forms around the ubiquitinated cargo [23,28,29]. LC3, a critical component of the autophagosomal membrane, is recruited via the p62 LC3-interacting region (LIR). Interestingly, the LIR also plays a role in p62 condensation since its mutation results in decreased p62 condensate formation both in vitro and in vivo [23]. This dual effect of the LIR on LC3 recruitment and in p62 condensation suggests an intriguing mechanism whereby the LIR may act as a regulatory switch between the recruitment of autophagosomal cargo into dense condensates and its subsequent engulfment by the autophagosomal membrane, which forms upon LC3 binding to the p62 LIR [23]. In contrast to the role of cytoplasmic p62 condensates in the autophagic process, nuclear p62 condensates function as sites of active UPS activity, recruiting active proteasomes to initiate the degradation of ubiquitinated substrates in a manner analogous to the RAD23B condensates described above [19].
In another case, UBQLN2, a ubiquitin-binding shuttle that promotes degradation of ubiquitinated protein substrates in the proteasome [25], forms condensates in the cell’s nucleus and cytoplasm [25,30,31,32,33]. UBQLN2 is crucial to the cellular response to proteotoxic stress and loss of UBQLN2 results in increased cell death [25]. However, as opposed to p62 and RAD23B condensates, UBQLN2-positive condensates disassemble in response to the addition of ubiquitin chains [32], suggesting a low threshold of saturation and competitive inhibition by ubiquitin chains (Figure 1) [20,21]. In addition, NF-κB essential modulator (NEMO) forms condensates via multivalent interactions with polyubiquitin chains. The formation of these condensates is required for activation of the IκB kinase (IKK) complex upstream of NF-κB signaling [34,35].
Cells 11 02415 g001 550
Figure 1. (A) Formation of nuclear p62 UPS condensates. Proteotoxic stress causes an increase in the number of ubiquitinated substrates, which require degradation. Polyubiquitin chains function as multivalent molecules, which drive condensation by binding to the UBA domain of p62. Oligomerization of p62 further contributes to multivalency. p62 recruits proteasomes to the condensate via its UBL domain. A similar mechanism drives the formation of RAD23B condensates, with the exception that RAD23B is not known to form oligomers like p62. (B) Model for UBQLN2-mediated extraction of ubiquitinated proteins from cytoplasmic SGs, consistent with the one proposed by [32]. SGs assemble via multivalent interactions between RNA-binding proteins and RNA. UBQLN2 enters SGs via its intrinsic phase separation propensity for phase separation. Once in SGs, UBQLN2 binding to ubiquitin chains causes it to dissociate from SGs, carrying with it bound ubiquitin-conjugated proteins. These are then likely delivered to the proteasome for degradation.
Figure 1. (A) Formation of nuclear p62 UPS condensates. Proteotoxic stress causes an increase in the number of ubiquitinated substrates, which require degradation. Polyubiquitin chains function as multivalent molecules, which drive condensation by binding to the UBA domain of p62. Oligomerization of p62 further contributes to multivalency. p62 recruits proteasomes to the condensate via its UBL domain. A similar mechanism drives the formation of RAD23B condensates, with the exception that RAD23B is not known to form oligomers like p62. (B) Model for UBQLN2-mediated extraction of ubiquitinated proteins from cytoplasmic SGs, consistent with the one proposed by [32]. SGs assemble via multivalent interactions between RNA-binding proteins and RNA. UBQLN2 enters SGs via its intrinsic phase separation propensity for phase separation. Once in SGs, UBQLN2 binding to ubiquitin chains causes it to dissociate from SGs, carrying with it bound ubiquitin-conjugated proteins. These are then likely delivered to the proteasome for degradation.
Cells 11 02415 g001
Finally, the nuclear speckle (NS)-localized E3 ligase SPOP [36,37,38] has been shown to form nuclear condensates (distinct from NS) in cells when coexpressed with model substrates [39,40,41] and also forms liquid droplets in vitro [41]. Importantly, mutation of the SPOP oligomerization domains inhibit its incorporation into nuclear condensates in cells and prevents its ability to undergo LLPS in vitro, demonstrating that SPOP oligomers function as multivalent biomolecular entities which promote condensation [39,41]. Consistent with the proposed function of p62 and RAD23B nuclear condensates, SPOP nuclear condensates function as sites of active ubiquitination [41], and decreasing SPOP valency by mutation of the oligomerization domains reduces its ubiquitination efficiency [39,41]. It has been proposed that NS may function as sites of storage for SPOP when substrate levels are low, whereby increased substrate levels during cellular stress results in dissociation of SPOP from NS and condensation together with substrates into phase-separated condensates in which efficient ubiquitination occurs [41].

2.3. Additional Aspects of Multivalent Interactions in Ubiquitin Condensates

Multivalent interactions between ubiquitin-binding shuttle proteins (e.g., RAD23B or p62) and ubiquitinated peptides display additional layers of complexity: longer polyubiquitin chains provide more binding sites and thus increase valency [19,26]. Importantly, the relative concentrations of ubiquitin-binding shuttle proteins and ubiquitin chains dictate whether the system will condense or will remain soluble. This notion is illustrated by the effect of polyubiquitin chains on the morphology of p62 oligomers. At a low ubiquitin:p62 ratio, p62 assembles into round assemblies while saturating ubiquitin concentrations result in complete disassembly of p62 clusters, an effect which depends on the p62 UBA domain [21]. A lower ubiquitin:p62 ratio promotes the clustering of p62 by allowing each ubiquitin chain to preferentially interact with multiple p62 molecules. However, too many polyubiquitin molecules will instead favor interaction with a few p62 molecules, preventing condensation and effectively reducing the valency of polyubiquitin chains with respect to its interaction with p62 [20].
Concentration-dependent interplay between two components in control of phase behavior is essentially similar to the effect of RNA:protein ratio on valency [20,42,43,44] and illustrates that optimization of relative constituent concentrations governs condensate behavior.
Finally, the ubiquitin chain linkage type regulates condensate specificity and function. RAD23 condensates primarily contains Lysine 48 (K48), whereby the ubiquitinated proteins are often routed to proteasomal degradation [19,26,29,45,46]. In contrast, p62 nuclear condensates predominantly contain Lysine 63 (K63). K63 Ubiquitin chains undergo more efficient phase separation and are associated with lysosomal/autophagosomal protein degradation [17]. K63 ubiquitin chains are also the drivers of NEMO condensation, in which IKK is activated [34,35].
Together, it becomes clear that UPS activity preferentially appears in condensates. Condensation increases the efficiency of the UPS, which is critical for coping with the load of proteasomal ubiquitinated substrates under stressful cellular conditions. UBQLN2, p62, NEMO, and RAD23B all induce condensation behavior through binding of ubiquitinated proteins. The underlying biochemical principle is that propensity to condense, conveyed by multivalency, enables molecular crowding, and facilitates specific enzymatic activities. The existence of distinct condensates, with different molecular compositions and at specific cellular locations, imply that they might address related but separate properties and cellular needs.
These findings allude to the existence of a new family of membraneless condensates, in which ubiquitin conjugation and proteasomal degradation are coupled in high proximity within the same compartment. The existence of E1-E2-E3 cascade components, as described in the p62 condensates, imply higher ubiquitination processivity, and may be found also in other (e.g., RAD23B-positive) condensates. In addition, the internal organization of p62 nuclear condensates comprising an internal core of polyubiquitinated proteins that are surrounded by a p62-positive phase and an outer shell containing active proteasomes is intriguing and can be sought in other UPS-associated organelles. Such multi-phased condensates have been described, including stress granules [47,48,49] and the nucleolus [47], and may reveal shared principles in condensate biology for controlled successive steps. In the case of UPS condensates, this may be to allow stepwise ubiquitin conjugation and execution of proteasomal degradation.

3. Molecular Mechanisms of Proteostasis Converge on Cytoplasmic Stress Granules

3.1. Stress Granules and the Integrated Stress Response

Upon exposure to a variety of proteotoxic stressors, mammalian cells activate an adaptive cellular response known as the integrated stress response (ISR) to allow coping and recovery from the stressful conditions. The ISR involves a specific signal via any of four specialized kinases (PKR, PERK, GCN2, or HRI), which phosphorylate the translation-initiation factor eIF2a, at serine 51. This specific phosphorylation of eIF2a arrests protein translation, while concurrently promoting the selective translation of certain 5′ upstream ORF-bearing transcripts, which culminates in the activation of a network of key genes involved in proteostatic maintenance [50]. The ISR, via eIF2a phosphorylation, also involves the assembly of SGs. Akin to other condensates, stress granule (SG) condensation is driven by multivalent molecular interactions between RNA-binding proteins (RBPs) and non-translating mRNA. Weak electrostatic interactions between intrinsically disordered regions of the proteins further contribute to valency and condensation. Importantly, SGs swiftly dissolve back into the cytoplasm upon recovery from the stressful stimulus [51,52,53].
The protein GAP SH3 Domain-Binding Protein 1 (G3BP1) is the key driver of stress granule condensation and has been shown to reside in pre-stress granule complexes, under unstressed conditions [48,54,55,56]. Translation initiation complex proteins and dozens of other RBPs incorporate into the condensates and further drive their assembly. Furthermore, several RBPs which are involved in nuclear mRNA biogenesis processes, translocate into the cytoplasm under stress, where they are incorporated into SGs. The associated nuclear depletion contributes to the global reduction in protein synthesis [57].

3.2. Proteostasis Factors Regulate SG Dynamics

Ubiquitin has been shown to accumulate in SGs upon proteotoxic stress [58,59,60,61], however the potential role of the UPS in SGs is not well-understood. Polyubiquitinated proteins have been detected in SGs, a substantial fraction of which likely represents defective ribosomal products (DRiPs) which are nascent polypeptides prone to aggregation [61,62]. Some evidence suggests that other misfolding-prone polyubiquitinated proteins accumulate into SGs as well [63,64], but this is not yet conclusive and whether active ubiquitination takes place inside these condensates remains to be determined. It is possible that misfolded proteins are actively directed into SGs via specific cellular processes, such as by the activity of HSP70/HSP40 chaperones [65], or that misfolded proteins exhibit a passive propensity to accumulate into condensates, thereby carrying polyubiquitin chains with them. Whatever the molecular mechanism is, sequestration of misfolded proteins inside SGs may mitigate aggregation or contain it during times of proteotoxic stress. Accordingly, excess of misfolded proteins or insufficiency of refolding or degradation pathways may lead to excessive accumulation of misfolded proteins within SGs and derail their normal liquidity, driving them towards irreversible aggregation [62,63,66].
A few mechanisms have been described, by which proteostasis regulators contribute to SG dynamics. First, several molecular chaperones are recruited to SGs and are required for proper SG dynamics. DnaJ heat-shock protein 40 kD (Hsp40) interact with HSP70, and these co-chaperones contribute to SG assembly/disassembly dynamics [62,63,67,68,69,70]. The HSP70-HSP40 complex functions both in regulation of SG RBP condensation [67,69] but also takes part in dealing with the load of misfolded proteins accumulating in SGs [62,63]. This is likely by refolding activity and by recruiting the E3 ligase CHIP to mark irreversibly damaged proteins for proteasomal degradation [71].

3.3. Ubiquitin Signaling in SGs

The ubiquitin-selective segregase VCP/p97, which extracts ubiquitinated substrates from protein complexes, is crucial for SG disassembly [58,60,72,73,74]. Ubiquitination may also function as a signal for the VCP-mediated removal of specific SG proteins during condensate demixing. In support of this, a recent report demonstrated that VCP is involved in the extraction of K63-polyubiquitinated G3BP1 from SGs as a part of their disassembly [58], suggesting precise control of a specific key protein by ubiquitin conjugation in contrast to the mass action of weak multivalent interactions in p62 or RAD23B condensates.
E1 ubiquitin-activating enzyme is also critical for SG disassembly. However, some types of stressors induce SGs that are largely devoid of polyubiquitin and relatively resilient to inhibition of E1 ubiquitin-activating enzyme (e.g., sodium arsenite) [59,60,63,75,76,77], whereas polyubiquitination is evident with other stress cues, such as heat shock (HS). Accordingly, the disassembly of HS-initiated SGs is sensitive to inhibition of E1 ubiquitin activity [58,59,60,63,75]. A clue for the regulatory mechanism acting in SGs to degrade ubiquitinated substrates may be associated with UBQLN2. Thus, UBQLN2 is recruited into SGs where it binds to misfolded ubiquitinated substrates. In an elegant autoregulation mechanism, the binding of ubiquitinated substrates causes UBQLN2 to dissociate from SGs back into the cytoplasm, directing its bound substrates to degradation [20,32,78]. It is interesting to hypothesize that SGs’ liquid-like environment is a niche that is biochemically favorable for handling UPS and also HSP70-DNAJ client proteins [79]. Furthermore, ubiquitin conjugation and an autophagic flux are required for degradation of misfolded proteins. Insufficiency in these proteostatic mechanisms may result in ubiquitinated protein accumulation inside SGs and transition into a persistent aberrant state.

3.4. Linking SUMO and StUbL to SGs

Small Ubiquitin-like Modifier (SUMO) is a ubiquitin-like moiety that is critical for SG dynamics. SUMO is necessary for SG assembly, presumably via increasing valency by producing interaction space for SUMO-conjugated peptides with SUMO interacting domains (SUMO glue model). This “glue-like” mechanism has been well described for promyelocytic leukemia (PML) protein nuclear bodies (NBs) where SUMOylation has been shown to drive the assembly and maturation of PML NBs by recruitment of SUMO interacting motif (SIM)-containing proteins [80,81]. A similar role for SUMOylation was recently reported in SG dynamics [48]. In addition, SUMOylation regulates disassembly by recruitment of the SUMO-targeted ubiquitin ligase (StUbL) pathway. StUbL results in ubiquitination of SUMOylated substrates by the E3 ubiquitin ligase RNF4 [82,83] and downstream proteasomal degradation. This mechanism is known to be critically involved in disassembly of PML NBs, where recruitment of the StUbL RNF4 results in degradation of PML protein [84,85]. In SGs, it is interesting to speculate that the dual SUMO function in SG assembly and disassembly, is biochemically coded by a transition from monoSUMOylation to polySUMOylation, but this remains to be explicitly tested experimentally [82]. SUMO-triggered and RNF4-mediated ubiquitination in both SGs and PML nuclear bodies reveal shared molecular mechanisms that govern the regulation of different condensates and expand the impact of ubiquitin-related post-translational modifications on condensate biology.

4. Stress Granules and Neuronal Inclusions in Amyotrophic Lateral Sclerosis

4.1. ALS and Cellular Proteostasis

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative syndrome of the human motor neuron system, which resides on a clinical, genetic and pathology continuum with frontotemporal dementia (FTD), a form of early onset dementia. The major neuropathological hallmark of a human brain from a patient suffering from ALS and/or FTD, is the presence of ubiquitinated and hyper phosphorylated TDP-43 in neuronal inclusions [86]. Other RBPs have been detected in neurodegeneration-associated brain inclusion as well, although more variably. Furthermore, cellular proteostasis components such as UBQLN2, p62, OPTN, heat shock proteins and VCP were found in ALS-associated inclusions [30,87,88,89,90,91,92,93,94,95,96,97]. These observations associate altered proteostasis capacity with ALS pathogenesis.

4.2. Aberrant SG Condensation May Lead to ALS Inclusion Formation

SGs make an intriguing cellular model for inclusions and may therefore be informative about mechanisms related to inclusion formation in the diseased brain [98,99,100,101]. Failed proteostasis causes the accumulation of damaged/misfolded proteins into SGs leading to aberrant condensation [62,63,66] and may be related to factors such as HSP70, VCP or UBQLN2 that localize to SGs [32,58,62,63,74]. In addition, several SG resident proteins are identified in inclusions [102,103,104], or are encoded by genes that are associated with ALS that are associated with ALS.
Finally, the ALS-associated hexanucleotide repeat expansion in C9ORF72, which is the most common genetic cause of ALS and FTD, provides several connections to SG biology: loss of normal C9ORF72 function impairs the interaction with p62 and normal autophagy [76], pathological dipeptide proteins that are generated in C9ORF72 disease incorporate into SGs, form cytotoxic aggregates and impair normal SG dynamics [48,105,106], in part by induction of ER stress [107,108] and in part by sequestering the proteasome [92,93].

4.3. Central Proteostasis Pathways Regulate ALS Pathogenesis

The molecular properties that allow UBQLN2 to act as a negative regulator of SG formation, equally promote the clearance of aggregates in C9ORF72 and FUS models of ALS [20,24,32,78]. However, ALS-causing mutations in the UBQLN2 gene, primarily at the protein’s low-complexity PXX domain [30,32], partially interfere with its ability to suppress SG formation [78]. A direct link ties UBQLN2 and HSP70, a chaperone that is central to protein disaggregation. The formation of a UBQLN2-HSP70 complex promotes aggregated protein degradation via the proteasome, including of C9orf72 dipeptides [24,25]. In addition, molecular co-chaperones of HSP70, such as BAG and DnaJ family proteins, are also involved in disaggregation of misfolded proteins in both SGs and ALS models [24,62,67]. Together, a UBQLN2-HSP70 axis serves a key disaggregase mechanism that is impaired in ALS and impact aberrant SGs or some related condensate entities that seeds the formation of ALS-associated inclusions in motor neurons. Interestingly, the proteins which are identified in ALS inclusions are more supersaturated in motor neurons than in other human cell types, pointing to a specific susceptibility of motor neurons to protein aggregation [3,4,5]. Conceivably, impaired neuronal proteostasis leads to aggregation of supersaturated proteins, however whether such supersaturated proteins accumulate into SGs remains to be determined.

5. Summary

The formation of protein aggregates is a pathological feature present among many neurodegenerative diseases, including ALS. Inclusions typical of ALS neuropathology and SGs share several molecular features. Decompensated proteostasis mechanisms or excess protein aggregation results in accumulation of ubiquitinated proteins into SGs, causing them to transform into an aberrant state characterized by reduced disassembly kinetics and persistence in the cytoplasm (Figure 2). Similar proteostasis abnormalities are deleterious to cells and drive nerve cell death in ALS. Future studies will likely focus on delineating the specific proteostasis factors, which either promote or inhibit protein aggregation within SGs and other condensates.

Author Contributions

E.A. and E.H. conceived the review, wrote the original draft, addressed the concerns of the reviewers and approved the final version. All authors have read and agreed to the published version of the manuscript.

Funding

Research at the Hornstein laboratory is supported by Andrea L. and Lawrence A. Wolfe Family Center for Research on Neuroimmunology and Neuromodulation, the CReATe consortium and ALSA (program: “Prognostic Value of miRNAs in Biofluids From ALS Patients”); the RADALA Foundation; AFM Telethon (20576); the Weizmann–Brazil Center for Research on Neurodegeneration at Weizmann Institute of Science; the Minerva Foundation, with funding from the Federal German Ministry for Education and Research; the ISF Legacy Heritage Fund (828/17); the Israel Science Foundation (135/16, 3497/21, 424/22, 425/22); Target ALS (118945); the Thierry Latran Foundation for ALS Research; the European Research Council under the European Union’s Seventh Framework Program ([FP7/2007–2013]/ERC grant agreement number 617351); United States-Israel Binational Science Foundation (#2021181); ERA-Net for Research Programs on Rare Diseases (eRARE FP7) via the Israel Ministry of Health; Dr Sydney Brenner and friends; Edward and Janie Moravitz; A. Alfred Taubman through IsrALS; Yeda-Sela; Yeda-CEO; the Israel Ministry of Trade and Industry; the Y. Leon Benoziyo Institute for Molecular Medicine; the Nella and Leon Benoziyo Center for Neurological Diseases; the Kekst Family Institute for Medical Genetics; the David and Fela Shapell Family Center for Genetic Disorders Research; the Crown Human Genome Center; the Nathan, Shirley, Philip, and Charlene Vener New Scientist Fund; the Julius and Ray Charlestein Foundation; the Fraida Foundation; the Wolfson Family Charitable Trust; the Adelis Foundation; Merck (UK); M. Halphen; the estates of F. Sherr, L. Asseof, and L. Fulop; and the Goldhirsh-Yellin Foundation; the Redhill Foundation–Sam and Jean Rothberg Charitable Trust; Dr. Dvora and Haim Teitelbaum Endowment Fund; A research grant from the Anita James Rosen Foundation.

Institutional Review Board Statement

This piece exempts review by the Weizmann Institutional review board.

Informed Consent Statement

Human subjects were not involved and hence informed consents were not used in the review piece.

Data Availability Statement

All data for this review is based on publicly available literature in pubmed.

Acknowledgments

E.H. is the Mondry Family Professorial Chair and Head of the Andrea L. and Lawrence A. Wolfe Family Center for Research on Neuroimmunology and Neuromodulation.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Hetz, C. Adapting the proteostasis capacity to sustain brain healthspan. Cell 2021, 184, 1545–1560. [Google Scholar] [CrossRef] [PubMed]
  2. Hipp, M.S.; Kasturi, P.; Hartl, F.U. The proteostasis network and its decline in ageing. Nat. Rev. Mol. Cell Biol. 2019, 20, 421–435. [Google Scholar] [CrossRef] [PubMed]
  3. Ciryam, P.; Tartaglia, G.G.; Morimoto, R.I.; Dobson, C.M.; Vendruscolo, M. Widespread Aggregation and Neurodegenerative Diseases Are Associated with Supersaturated Proteins. Cell Rep. 2013, 5, 781–790. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  4. Ciryam, P.; Lambert-Smith, I.A.; Bean, D.M.; Freer, R.; Cid, F.; Tartaglia, G.G.; Saunders, D.N.; Wilson, M.R.; Oliver, S.G.; Morimoto, R.I.; et al. Spinal motor neuron protein supersaturation patterns are associated with inclusion body formation in ALS. Proc. Natl. Acad. Sci. USA 2017, 114, E3935–E3943. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  5. Yerbury, J.J.; Ooi, L.; Blair, I.P.; Ciryam, P.; Dobson, C.M.; Vendruscolo, M. The metastability of the proteome of spinal motor neurons underlies their selective vulnerability in ALS. Neurosci. Lett. 2019, 704, 89–94. [Google Scholar] [CrossRef] [PubMed]
  6. Tartaglia, G.G.; Vendruscolo, M. Correlation between mRNA expression levels and protein aggregation propensities in subcellular localisations. Mol. BioSyst. 2009, 5, 1873–1876. [Google Scholar] [CrossRef] [PubMed]
  7. Tartaglia, G.G.; Pechmann, S.; Dobson, C.M.; Vendruscolo, M. Life on the edge: A link between gene expression levels and aggregation rates of human proteins. Trends Biochem. Sci. 2007, 32, 204–206. [Google Scholar] [CrossRef]
  8. Tartaglia, G.G.; Vendruscolo, M. The Zyggregator method for predicting protein aggregation propensities. Chem. Soc. Rev. 2008, 37, 1395–1401. [Google Scholar] [CrossRef]
  9. Balchin, D.; Hayer-Hartl, M.; Hartl, F.U. In vivo aspects of protein folding and quality control. Science 2016, 353, aac4354. [Google Scholar] [CrossRef]
  10. Hartl, F.U.; Bracher, A.; Hayer-Hartl, M. Molecular chaperones in protein folding and proteostasis. Nature 2011, 475, 324–332. [Google Scholar] [CrossRef]
  11. Lyon, A.S.; Peeples, W.B.; Rosen, M.K. A framework for understanding the functions of biomolecular condensates across scales. Nat. Rev. Mol. Cell Biol. 2020, 22, 215–235. [Google Scholar] [CrossRef]
  12. Banani, S.F.; Lee, H.O.; Hyman, A.A.; Rosen, M.K. Biomolecular condensates: Organizers of cellular biochemistry. Nat. Rev. Mol. Cell Biol. 2017, 18, 285–298. [Google Scholar] [CrossRef]
  13. Shin, Y.; Brangwynne, C.P. Liquid phase condensation in cell physiology and disease. Science 2017, 357, eaaf4382. [Google Scholar] [CrossRef] [Green Version]
  14. Kwon, Y.T.; Ciechanover, A. The Ubiquitin Code in the Ubiquitin-Proteasome System and Autophagy. Trends Biochem. Sci. 2017, 42, 873–886. [Google Scholar] [CrossRef]
  15. Dikic, I. Proteasomal and Autophagic Degradation Systems. Annu. Rev. Biochem. 2017, 86, 193–224. [Google Scholar] [CrossRef]
  16. Shaid, S.; Brandts, C.H.; Serve, H.; Dikic, I. Ubiquitination and selective autophagy. Cell Death Differ. 2012, 20, 21–30. [Google Scholar] [CrossRef]
  17. Komander, D.; Rape, M. The ubiquitin code. Annu. Rev. Biochem. 2012, 10, 203–229. [Google Scholar] [CrossRef] [Green Version]
  18. Zientara-Rytter, K.; Subramani, S. The Roles of Ubiquitin-Binding Protein Shuttles in the Degradative Fate of Ubiquitinated Proteins in the Ubiquitin-Proteasome System and Autophagy. Cells 2019, 8, 40. [Google Scholar] [CrossRef] [Green Version]
  19. Fu, A.; Cohen-Kaplan, V.; Avni, N.; Livneh, I.; Ciechanover, A. p62-containing, proteolytically active nuclear condensates, increase the efficiency of the ubiquitin–proteasome system. Proc. Natl. Acad. Sci. USA 2021, 118, e2107321118. [Google Scholar] [CrossRef]
  20. Dao, T.P.; Castañeda, C.A. Ubiquitin-Modulated Phase Separation of Shuttle Proteins: Does Condensate Formation Promote Protein Degradation? Bioessays 2020, 42, e2000036. [Google Scholar] [CrossRef]
  21. Ciuffa, R.; Lamark, T.; Tarafder, A.K.; Guesdon, A.; Rybina, S.; Hagen, W.J.; Johansen, T.; Sachse, C. The Selective Autophagy Receptor p62 Forms a Flexible Filamentous Helical Scaffold. Cell Rep. 2015, 11, 748–758. [Google Scholar] [CrossRef] [Green Version]
  22. Cabe, M.; Rademacher, D.J.; Karlsson, A.B.; Cherukuri, S.; Bakowska, J.C. PB1 and UBA domains of p62 are essential for aggresome-like induced structure formation. Biochem. Biophys. Res. Commun. 2018, 503, 2306–2311. [Google Scholar] [CrossRef]
  23. Zaffagnini, G.; Savova, A.; Danieli, A.; Romanov, J.; Tremel, S.; Ebner, M.; Peterbauer, T.; Sztacho, M.; Trapannone, R.; Tarafder, A.K.; et al. p62 filaments capture and present ubiquitinated cargos for autophagy. EMBO J. 2018, 37, e98308. [Google Scholar] [CrossRef]
  24. Zhang, K.; Wang, A.; Zhong, K.; Qi, S.; Wei, C.; Shu, X.; Tu, W.-Y.; Xu, W.; Xia, C.; Xiao, Y.; et al. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model. Neuron 2021, 109, 1949–1962.e6. [Google Scholar] [CrossRef]
  25. Hjerpe, R.; Bett, J.S.; Keuss, M.J.; Solovyova, A.; McWilliams, T.G.; Johnson, C.; Sahu, I.; Varghese, J.; Wood, N.; Wightman, M.; et al. UBQLN2 Mediates Autophagy-Independent Protein Aggregate Clearance by the Proteasome. Cell 2016, 166, 935–949. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  26. Yasuda, S.; Tsuchiya, H.; Kaiho, A.; Guo, Q.; Ikeuchi, K.; Endo, A.; Arai, N.; Ohtake, F.; Murata, S.; Inada, T.; et al. Stress- and ubiquitylation-dependent phase separation of the proteasome. Nature 2020, 578, 296–300. [Google Scholar] [CrossRef] [PubMed]
  27. Finley, D. Recognition and Processing of Ubiquitin-Protein Conjugates by the Proteasome. Annu. Rev. Biochem. 2009, 78, 477–513. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  28. Kageyama, S.; Gudmundsson, S.R.; Sou, Y.S.; Ichimura, Y.; Tamura, N.; Kazuno, S.; Ueno, T.; Miura, Y.; Noshiro, D.; Abe, M.; et al. p62/SQSTM1-droplet serves as a platform for autophagosome formation and anti-oxidative stress response. Nat. Commun. 2021, 12, 16. [Google Scholar] [CrossRef]
  29. Sun, D.; Wu, R.; Zheng, J.; Li, P.; Yu, L. Polyubiquitin chain-induced p62 phase separation drives autophagic cargo segregation. Cell Res. 2018, 28, 405–415. [Google Scholar] [CrossRef] [Green Version]
  30. Deng, H.-X.; Chen, W.; Hong, S.-T.; Boycott, K.M.; Gorrie, G.H.; Siddique, N.; Yang, Y.; Fecto, F.; Shi, Y.; Zhai, H.; et al. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia. Nat. 2011, 477, 211–215. [Google Scholar] [CrossRef] [Green Version]
  31. Riley, J.F.; Fioramonti, P.J.; Rusnock, A.K.; Hehnly, H.; Castañeda, C.A. ALS-linked mutations impair UBQLN2 stress-induced biomolecular condensate assembly in cells. J. Neurochem. 2021, 159, 145–155. [Google Scholar] [CrossRef]
  32. Dao, T.P.; Kolaitis, R.-M.; Kim, H.J.; O’Donovan, K.; Martyniak, B.; Colicino, E.; Hehnly, H.; Taylor, J.P.; Castañeda, C.A. Ubiquitin Modulates Liquid-Liquid Phase Separation of UBQLN2 via Disruption of Multivalent Interactions. Mol. Cell 2018, 69, 965–978.e6. [Google Scholar] [CrossRef] [Green Version]
  33. Dao, T.P.; Martyniak, B.; Canning, A.J.; Lei, Y.; Colicino, E.G.; Cosgrove, M.S.; Hehnly, H.; Castañeda, C.A. ALS-Linked Mutations Affect UBQLN2 Oligomerization and Phase Separation in a Position- and Amino Acid-Dependent Manner. Structure 2019, 27, 937–951.e5. [Google Scholar] [CrossRef]
  34. Scholefield, J.; Henriques, R.; Savulescu, A.; Fontan, E.; Boucharlat, A.; Laplantine, E.; Smahi, A.; Israël, A.; Agou, F.; Mhlanga, M.M. Super-resolution microscopy reveals a preformed NEMO lattice structure that is collapsed in incontinentia pigmenti. Nat. Commun. 2016, 7, 12629. [Google Scholar] [CrossRef] [Green Version]
  35. Du, M.; Ea, C.-K.; Fang, Y.; Chen, Z.J. Liquid phase separation of NEMO induced by polyubiquitin chains activates NF-κB. Mol. Cell 2022, 82, 2415–2426.e5. [Google Scholar] [CrossRef]
  36. Gałgański, Ł.; Urbanek-Trzeciak, M.O.; Krzyzosiak, W.J. Nuclear speckles: Molecular organization, biological function and role in disease. Nucleic Acids Res. 2017, 45, 10350–10368. [Google Scholar] [CrossRef] [Green Version]
  37. Liu, S.; Wang, T.; Shi, Y.; Bai, L.; Wang, S.; Guo, D.; Zhang, Y.; Qi, Y.; Chen, C.; Zhang, J.; et al. USP42 drives nuclear speckle mRNA splicing via directing dynamic phase separation to promote tumorigenesis. Cell Death Differ. 2021, 28, 2482–2498. [Google Scholar] [CrossRef]
  38. Nagai, Y.; Kojima, T.; Muro, Y.; Hachiya, T.; Nishizawa, Y.; Wakabayashi, T.; Hagiwara, M. Identification of a novel nuclear speckle-type protein, SPOP. FEBS Lett. 1997, 418, 23–26. [Google Scholar] [CrossRef] [Green Version]
  39. Marzahn, M.R.; Marada, S.; Lee, J.; Nourse, A.; Kenrick, S.; Zhao, H.; Ben-Nissan, G.; Kolaitis, R.; Peters, J.L.; Pounds, S.; et al. Higher-order oligomerization promotes localization of SPOP to liquid nuclear speckles. EMBO J. 2016, 35, 1254–1275. [Google Scholar] [CrossRef]
  40. Usher, E.T.; Sabri, N.; Rohac, R.; Boal, A.K.; Mittag, T.; Showalter, S.A. Intrinsically disordered substrates dictate SPOP subnuclear localization and ubiquitination activity. J. Biol. Chem. 2021, 296, 100693. [Google Scholar] [CrossRef]
  41. Bouchard, J.J.; Otero, J.H.; Scott, D.C.; Szulc, E.; Martin, E.W.; Sabri, N.; Granata, D.; Marzahn, M.R.; Lindorff-Larsen, K.; Salvatella, X.; et al. Cancer Mutations of the Tumor Suppressor SPOP Disrupt the Formation of Active, Phase-Separated Compartments. Mol. Cell 2018, 72, 19–36.e8. [Google Scholar] [CrossRef] [Green Version]
  42. Maharana, S.; Wang, J.; Papadopoulos, D.K.; Richter, D.; Pozniakovsky, A.; Poser, I.; Bickle, M.; Rizk, S.; Guillén-Boixet, J.; Franzmann, T.M.; et al. RNA buffers the phase separation behavior of prion-like RNA binding proteins. Science 2018, 360, 918–921. [Google Scholar] [CrossRef] [Green Version]
  43. Baradaran-Heravi, Y.; Van Broeckhoven, C.; van der Zee, J. Stress granule mediated protein aggregation and underlying gene defects in the FTD-ALS spectrum. Neurobiol. Dis. 2019, 134, 104639. [Google Scholar] [CrossRef]
  44. Alshareedah, I.; Kaur, T.; Ngo, J.; Seppala, H.; Kounatse, L.-A.D.; Wang, W.; Moosa, M.M.; Banerjee, P.R. Interplay between Short-Range Attraction and Long-Range Repulsion Controls Reentrant Liquid Condensation of Ribonucleoprotein–RNA Complexes. J. Am. Chem. Soc. 2019, 141, 14593–14602. [Google Scholar] [CrossRef]
  45. Varadan, R.; Assfalg, M.; Raasi, S.; Pickart, C.; Fushman, D. Structural Determinants for Selective Recognition of a Lys48-Linked Polyubiquitin Chain by a UBA Domain. Mol. Cell 2005, 18, 687–698. [Google Scholar] [CrossRef]
  46. Raasi, S.; Varadan, R.; Fushman, D.; Pickart, C.M. Diverse polyubiquitin interaction properties of ubiquitin-associated domains. Nat. Struct. Mol. Biol. 2005, 12, 708–714. [Google Scholar] [CrossRef]
  47. Lafontaine, D.L.J.; Riback, J.A.; Bascetin, R.; Brangwynne, C.P. The nucleolus as a multiphase liquid condensate. Nat. Rev. Mol. Cell Biol. 2020, 22, 165–182. [Google Scholar] [CrossRef] [PubMed]
  48. Marmor-Kollet, H.; Siany, A.; Kedersha, N.; Knafo, N.; Rivkin, N.; Danino, Y.M.; Moens, T.G.; Olender, T.; Sheban, D.; Cohen, N.; et al. Spatiotemporal Proteomic Analysis of Stress Granule Disassembly Using APEX Reveals Regulation by SUMOylation and Links to ALS Pathogenesis. Mol. Cell 2020, 80, 876–891.e6. [Google Scholar] [CrossRef] [PubMed]
  49. Jain, S.; Wheeler, J.R.; Walters, R.W.; Agrawal, A.; Barsic, A.; Parker, R. ATPase-Modulated Stress Granules Contain a Diverse Proteome and Substructure. Cell 2016, 164, 487–498. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  50. Costa-Mattioli, M.; Walter, P. The integrated stress response: From mechanism to disease. Science 2020, 368, eaat5314. [Google Scholar] [CrossRef] [PubMed]
  51. Hofmann, S.; Kedersha, N.; Anderson, P.; Ivanov, P. Molecular mechanisms of stress granule assembly and disassembly. Biochim. et Biophys. Acta 2020, 1868, 118876. [Google Scholar] [CrossRef]
  52. Corbet, G.; Parker, R. RNP Granule Formation: Lessons from P-Bodies and Stress Granules. Cold Spring Harb. Symp. Quant. Biol. 2019, 84, 203–215. [Google Scholar] [CrossRef]
  53. Sanders, D.W.; Kedersha, N.; Lee, D.S.W.; Strom, A.R.; Drake, V.; Riback, J.A.; Bracha, D.; Eeftens, J.M.; Iwanicki, A.; Wang, A.; et al. Competing Protein-RNA Interaction Networks Control Multiphase Intracellular Organization. Cell 2020, 181, 306–324.e28. [Google Scholar] [CrossRef]
  54. Markmiller, S.; Soltanieh, S.; Server, K.L.; Mak, R.; Jin, W.; Fang, M.Y.; Luo, E.; Yeo, G.W.; Krach, F.; Yang, D.; et al. Context-dependent and Disease-specific Diversity in Stress Granules Formed from Pre-existing Protein Interactions. FASEB J. 2018, 32, 252-3. [Google Scholar] [CrossRef]
  55. Wheeler, J.R.; Matheny, T.; Jain, S.; Abrisch, R.; Parker, R. Distinct stages in stress granule assembly and disassembly. eLife 2016, 5, e18413. [Google Scholar] [CrossRef]
  56. Yang, P.; Mathieu, C.; Kolaitis, R.-M.; Zhang, P.; Messing, J.; Yurtsever, U.; Yang, Z.; Wu, J.; Li, Y.; Pan, Q.; et al. G3BP1 Is a Tunable Switch that Triggers Phase Separation to Assemble Stress Granules. Cell 2020, 181, 325–345.e28. [Google Scholar] [CrossRef]
  57. Kedersha, N.; Anderson, P. Chapter 4 Regulation of Translation by Stress Granules and Processing Bodies. Prog. Mol. Biol. Transl. Sci. 2009, 90, 155–185. [Google Scholar] [CrossRef]
  58. Gwon, Y.; Maxwell, B.A.; Kolaitis, R.-M.; Zhang, P.; Kim, H.J.; Taylor, J.P. Ubiquitination of G3BP1 mediates stress granule disassembly in a context-specific manner. Science 2021, 372, eabf6548. [Google Scholar] [CrossRef]
  59. Maxwell, B.A.; Gwon, Y.; Mishra, A.; Peng, J.; Nakamura, H.; Zhang, K.; Kim, H.J.; Taylor, J.P. Ubiquitination is essential for recovery of cellular activities after heat shock. Science 2021, 372, eabc3593. [Google Scholar] [CrossRef]
  60. Tolay, N.; Buchberger, A. Comparative profiling of stress granule clearance reveals differential contributions of the ubiquitin system. Life Sci. Alliance 2021, 4, e202000927. [Google Scholar] [CrossRef]
  61. Mediani, L.; Guillén-Boixet, J.; Vinet, J.; Franzmann, T.M.; Bigi, I.; Mateju, D.; Carrà, A.D.; Morelli, F.F.; Tiago, T.; Poser, I.; et al. Defective ribosomal products challenge nuclear function by impairing nuclear condensate dynamics and immobilizing ubiquitin. EMBO J. 2019, 38, e101341. [Google Scholar] [CrossRef]
  62. Ganassi, M.; Mateju, D.; Bigi, I.; Mediani, L.; Poser, I.; Lee, H.O.; Seguin, S.J.; Morelli, F.F.; Vinet, J.; Leo, G.; et al. A Surveillance Function of the HSPB8-BAG3-HSP70 Chaperone Complex Ensures Stress Granule Integrity and Dynamism. Mol. Cell 2016, 63, 796–810. [Google Scholar] [CrossRef] [Green Version]
  63. Mateju, D.; Franzmann, T.M.; Patel, A.; Kopach, A.; E Boczek, E.; Maharana, S.; O Lee, H.; Carra, S.; A Hyman, A.; Alberti, S. An aberrant phase transition of stress granules triggered by misfolded protein and prevented by chaperone function. EMBO J. 2017, 36, 1669–1687. [Google Scholar] [CrossRef]
  64. Samanta, N.; Ribeiro, S.S.; Becker, M.; Laborie, E.; Pollak, R.; Timr, S.; Sterpone, F.; Ebbinghaus, S. Sequestration of Proteins in Stress Granules Relies on the In-Cell but Not the In Vitro Folding Stability. J. Am. Chem. Soc. 2021, 143, 19909–19918. [Google Scholar] [CrossRef]
  65. Cabrera, M.; Boronat, S.; Marte, L.; Vega, M.; Pérez, P.; Ayté, J.; Hidalgo, E. Chaperone-Facilitated Aggregation of Thermo-Sensitive Proteins Shields Them from Degradation during Heat Stress. Cell Rep. 2020, 30, 2430–2443.e4. [Google Scholar] [CrossRef] [Green Version]
  66. Seguin, S.J.; Morelli, F.F.; Vinet, J.; Amore, D.; De Biasi, S.; Poletti, A.; Rubinsztein, D.C.; Carra, S. Inhibition of autophagy, lysosome and VCP function impairs stress granule assembly. Cell Death Differ. 2014, 21, 1838–1851. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Rozales, K.; Younis, A.; Saida, N.; Meller, A.; Goldman, H.; Kellerman, L.; Heinrich, R.; Berlin, S.; Shalgi, R. Differential roles for DNAJ isoforms in HTT-polyQ and FUS aggregation modulation revealed by chaperone screens. Nat. Commun. 2022, 13, 516. [Google Scholar] [CrossRef]
  68. Gu, J.; Liu, Z.; Zhang, S.; Li, Y.; Xia, W.; Wang, C.; Xiang, H.; Liu, Z.; Tan, L.; Fang, Y.; et al. Hsp40 proteins phase separate to chaperone the assembly and maintenance of membraneless organelles. Proc. Natl. Acad. Sci. USA 2020, 117, 31123–31133. [Google Scholar] [CrossRef] [PubMed]
  69. Yoo, H.; Bard, J.A.; Pilipenko, E.V.; Drummond, D.A. Chaperones directly and efficiently disperse stress-triggered biomolecular condensates. Mol. Cell 2022, 82, 741–755.e11. [Google Scholar] [CrossRef] [PubMed]
  70. Walters, R.W.; Muhlrad, D.; Garcia, J.; Parker, R. Differential effects of Ydj1 and Sis1 on Hsp70-mediated clearance of stress granules in Saccharomyces cerevisiae. RNA 2015, 21, 1660–1671. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  71. VanPelt, J.; Page, R.C. Unraveling the CHIP:Hsp70 complex as an information processor for protein quality control. Biochim. et Biophys. Acta (BBA)-Proteins Proteom. 2017, 1865, 133–141. [Google Scholar] [CrossRef] [Green Version]
  72. Meyer, H.; Weihl, C.C. The VCP/p97 system at a glance: Connecting cellular function to disease pathogenesis. J. Cell Sci. 2014, 127, 3877–3883. [Google Scholar] [CrossRef] [Green Version]
  73. Buchan, J.R.; Kolaitis, R.M.; Taylor, J.P.; Parker, R. Eukaryotic stress granules are cleared by autophagy and Cdc48/VCP function. Cell 2013, 153, 1461–1474. [Google Scholar] [CrossRef] [Green Version]
  74. Turakhiya, A.; Meyer, S.R.; Marincola, G.; Böhm, S.; Vanselow, J.T.; Schlosser, A.; Hofmann, K.; Buchberger, A. ZFAND1 Recruits p97 and the 26S Proteasome to Promote the Clearance of Arsenite-Induced Stress Granules. Mol Cell. 2018, 70, 906–919.e7. [Google Scholar] [CrossRef] [Green Version]
  75. Xie, X.; Matsumoto, S.; Endo, A.; Fukushima, T.; Kawahara, H.; Saeki, Y.; Komada, M. Deubiquitinases USP5 and USP13 are recruited to and regulate heat-induced stress granules by deubiquitinating activities. J. Cell Sci. 2018, 131, jcs.210856. [Google Scholar] [CrossRef] [Green Version]
  76. Chitiprolu, M.; Jagow, C.; Tremblay, V.; Bondy-Chorney, E.; Paris, G.; Savard, A.; Palidwor, G.; Barry, F.A.; Zinman, L.; Keith, J.; et al. A complex of C9ORF72 and p62 uses arginine methylation to eliminate stress granules by autophagy. Nat. Commun. 2018, 9, 1–18. [Google Scholar] [CrossRef] [Green Version]
  77. Markmiller, S.; Fulzele, A.; Higgins, R.; Leonard, M.; Yeo, G.W.; Bennett, E.J. Active Protein Neddylation or Ubiquitylation Is Dispensable for Stress Granule Dynamics. Cell Rep. 2019, 27, 1356–1363.e3. [Google Scholar] [CrossRef] [Green Version]
  78. Alexander, E.J.; Niaki, A.G.; Zhang, T.; Sarkar, J.; Liu, Y.; Nirujogi, R.S.; Pandey, A.; Myong, S.; Wang, J. Ubiquilin 2 modulates ALS/FTD-linked FUS–RNA complex dynamics and stress granule formation. Proc. Natl. Acad. Sci. USA 2018, 115, E11485–E11494. [Google Scholar] [CrossRef] [Green Version]
  79. Mee Hayes, E.; Sirvio, L.; Ye, Y. A Potential Mechanism for Targeting Aggregates With Proteasomes and Disaggregases in Liquid Droplets. Front. Aging Neurosci. 2022, 14, 854380. [Google Scholar] [CrossRef]
  80. Weidtkamp-Peters, S.; Lenser, T.; Negorev, D.; Gerstner, N.; Hofmann, T.G.; Schwanitz, G.; Hoischen, C.; Maul, G.; Dittrich, P.; Hemmerich, P. Dynamics of component exchange at PML nuclear bodies. J. Cell Sci. 2008, 121, 2731–2743. [Google Scholar] [CrossRef] [Green Version]
  81. Sung, K.S.; Lee, Y.-A.; Kim, E.T.; Lee, S.-R.; Ahn, J.-H.; Choi, C.Y. Role of the SUMO-interacting motif in HIPK2 targeting to the PML nuclear bodies and regulation of p53. Exp. Cell Res. 2011, 317, 1060–1070. [Google Scholar] [CrossRef]
  82. Keiten-Schmitz, J.; Röder, L.; Hornstein, E.; Müller-McNicoll, M.; Müller, S. SUMO: Glue or Solvent for Phase-Separated Ribonucleoprotein Complexes and Molecular Condensates? Front. Mol. Biosci. 2021, 8, 673038. [Google Scholar] [CrossRef]
  83. Keiten-Schmitz, J.; Wagner, K.; Piller, T.; Kaulich, M.; Alberti, S.; Müller, S. The Nuclear SUMO-Targeted Ubiquitin Quality Control Network Regulates the Dynamics of Cytoplasmic Stress Granules. Mol. Cell 2020, 79, 54–67.e7. [Google Scholar] [CrossRef]
  84. Lallemand-Breitenbach, V.; Jeanne, M.; Benhenda, S.; Nasr, R.; Lei, M.; Peres, L.; Zhou, J.; Zhu, J.; Raught, B.; de Thé, H. Arsenic degrades PML or PML-RARalpha through a SUMO-triggered RNF4/ubiquitin-mediated pathway. Nat. Cell Biol. 2008, 10, 547–555. [Google Scholar] [CrossRef]
  85. Lallemand-Breitenbach, V.; de Thé, H. PML nuclear bodies: From architecture to function. Curr. Opin. Cell. Biol. 2018, 52, 154–161. [Google Scholar] [CrossRef]
  86. Neumann, M.; Sampathu, D.M.; Kwong, L.K.; Truax, A.C.; Micsenyi, M.C.; Chou, T.T.; Bruce, J.; Schuck, T.; Grossman, M.; Clark, C.M.; et al. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis. Science 2006, 314, 130–133. [Google Scholar] [CrossRef] [Green Version]
  87. Li, F.; Xu, D.; Wang, Y.; Zhou, Z.; Liu, J.; Hu, S.; Gong, Y.; Yuan, J.; Pan, L. Structural insights into the ubiquitin recognition by OPTN (optineurin) and its regulation by TBK1-mediated phosphorylation. Autophagy 2018, 14, 66–79. [Google Scholar] [CrossRef] [Green Version]
  88. Keller, B.A.; Volkening, K.; Droppelmann, C.A.; Ang, L.C.; Rademakers, R.; Strong, M.J. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: Evidence of a common pathogenic mechanism. Acta Neuropathol. 2012, 124, 733–747. [Google Scholar] [CrossRef]
  89. Watanabe, M.; Dykes-Hoberg, M.; Cizewski Culotta, V.; Price, D.L.; Wong, P.C.; Rothstein, J.D. Histological Evidence of Protein Aggregation in Mutant SOD1 Transgenic Mice and in Amyotrophic Lateral Sclerosis Neural Tissues. Neurobiol. Dis. 2001, 8, 933–941. [Google Scholar] [CrossRef] [Green Version]
  90. Weisberg, S.J.; Lyakhovetsky, R.; Werdiger, A.-C.; Gitler, A.D.; Soen, Y.; Kaganovich, D. Compartmentalization of superoxide dismutase 1 (SOD1G93A) aggregates determines their toxicity. Proc. Natl. Acad. Sci. USA 2012, 109, 15811–15816. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  91. Basso, M.; Samengo, G.; Nardo, G.; Massignan, T.; D’Alessandro, G.; Tartari, S.; Cantoni, L.; Marino, M.; Cheroni, C.; De Biasi, S.; et al. Characterization of Detergent-Insoluble Proteins in ALS Indicates a Causal Link between Nitrative Stress and Aggregation in Pathogenesis. PLoS ONE 2009, 4, e8130. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  92. Guo, Q.; Lehmer, C.; Martínez-Sánchez, A.; Rudack, T.; Beck, F.; Hartmann, H.; Pérez-Berlanga, M.; Frottin, F.; Hipp, M.S.; Hartl, F.U.; et al. In Situ Structure of Neuronal C9orf72 Poly-GA Aggregates Reveals Proteasome Recruitment. Cell 2018, 172, 696–705.e12. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  93. Gupta, R.; Lan, M.; Mojsilovic-Petrovic, J.; Choi, W.H.; Safren, N.; Barmada, S.; Lee, M.J.; Kalb, R. The Proline/Arginine Dipeptide from Hexanucleotide Repeat Expanded C9ORF72 Inhibits the Proteasome. Eneuro 2017, 4. [Google Scholar] [CrossRef] [Green Version]
  94. Farrawell, N.E.; Lambert-Smith, I.; Mitchell, K.; McKenna, J.; McAlary, L.; Ciryam, P.; Vine, K.L.; Saunders, D.N.; Yerbury, J.J. SOD1A4V aggregation alters ubiquitin homeostasis in a cell model of ALS. J. Cell Sci. 2018, 131, jcs209122. [Google Scholar] [CrossRef] [Green Version]
  95. Farrawell, N.E.; McAlary, L.; Lum, J.S.; Chisholm, C.G.; Warraich, S.T.; Blair, I.P.; Vine, K.L.; Saunders, D.N.; Yerbury, J.J. Ubiquitin Homeostasis Is Disrupted in TDP-43 and FUS Cell Models of ALS. iScience 2020, 23, 101700. [Google Scholar] [CrossRef]
  96. Gami-Patel, P.; Dijken, I.; Meeter, L.H.; Melhem, S.; Morrema, T.H.J.; Scheper, W.; Swieten, J.C.; Rozemuller, A.J.M.; Dijkstra, A.A.; Hoozemans, J.J.M. Unfolded protein response activation in C9orf72 frontotemporal dementia is associated with dipeptide pathology and granulovacuolar degeneration in granule cells. Brain Pathol. 2020, 31, 163–173. [Google Scholar] [CrossRef]
  97. Farhan, S.M.K.; Howrigan, D.P.; Abbott, L.E.; Klim, J.R.; Topp, S.D.; Byrnes, A.E.; Churchhouse, C.; Phatnani, H.; Smith, B.N.; Rampersaud, E.; et al. Exome sequencing in amyotrophic lateral sclerosis implicates a novel gene, DNAJC7, encoding a heat-shock protein. Nat. Neurosci. 2019, 22, 1966–1974. [Google Scholar] [CrossRef]
  98. Dubinski, A.; Vande Velde, C. Altered stress granule disassembly: Links to neurodegenerative disease? Trends Neurosci. 2021, 44, 765–766. [Google Scholar] [CrossRef]
  99. Khalfallah, Y.; Kuta, R.; Grasmuck, C.; Prat, A.; Durham, H.D.; Velde, C.V. TDP-43 regulation of stress granule dynamics in neurodegenerative disease-relevant cell types. Sci. Rep. 2018, 8, 7551. [Google Scholar] [CrossRef] [Green Version]
  100. Li, Y.R.; King, O.D.; Shorter, J.; Gitler, A.D. Stress granules as crucibles of ALS pathogenesis. J. Cell Biol. 2013, 201, 361–372. [Google Scholar] [CrossRef]
  101. Wolozin, B.; Ivanov, P. Stress granules and neurodegeneration. Nat. Rev. Neurosci. 2019, 20, 649–666. [Google Scholar] [CrossRef] [PubMed]
  102. Deng, H.-X.; Zhai, H.; Bigio, E.H.; Yan, J.; Fecto, F.; Ajroud, K.; Mishra, M.; Ajroud-Driss, S.; Heller, S.; Sufit, R.; et al. FUS-immunoreactive inclusions are a common feature in sporadic and non-SOD1 familial amyotrophic lateral sclerosis. Ann. Neurol. 2010, 67, 739–748. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  103. Liu-Yesucevitz, L.; Bilgutay, A.; Zhang, Y.J.; Vanderweyde, T.; Citro, A.; Mehta, T.; Zaarur, N.; McKee, A.; Bowser, R.; Sherman, M.; et al. Tar DNA binding protein-43 (TDP-43) associates with stress granules: Analysis of cultured cells and pathological brain tissue. PLoS ONE 2010, 5, e13250. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Fujita, K.; Ito, H.; Nakano, S.; Kinoshita, Y.; Wate, R.; Kusaka, H. Immunohistochemical identification of messenger RNA-related proteins in basophilic inclusions of adult-onset atypical motor neuron disease. Acta Neuropathol. 2008, 116, 439–445. [Google Scholar] [CrossRef]
  105. Lee, K.-H.; Zhang, P.; Kim, H.J.; Mitrea, D.M.; Sarkar, M.; Freibaum, B.D.; Cika, J.; Coughlin, M.; Messing, J.; Molliex, A.; et al. C9orf72 Dipeptide Repeats Impair the Assembly, Dynamics, and Function of Membrane-Less Organelles. Cell 2016, 167, 774–788.e17. [Google Scholar] [CrossRef] [Green Version]
  106. Zhang, Y.J.; Gendron, T.F.; Ebbert, M.T.W.; O’Raw, A.D.; Yue, M.; Jansen-West, K.; Zhang, X.; Prudencio, M.; Chew, J.; Cook, C.N.; et al. Poly(GR) impairs protein translation and stress granule dynamics in C9orf72-associated frontotemporal dementia and amyotrophic lateral sclerosis. Nat. Med. 2018, 24, 1136–1142. [Google Scholar] [CrossRef]
  107. Prudencio, M.; Belzil, V.V.; Batra, R.; Ross, C.A.; Gendron, T.F.; Pregent, L.J.; Murray, M.E.; Overstreet, K.K.; Piazza-Johnston, A.E.; Desaro, P.; et al. Distinct brain transcriptome profiles in C9orf72-associated and sporadic ALS. Nat. Neurosci. 2015, 18, 1175–1182. [Google Scholar] [CrossRef]
  108. Wang, R.; Xu, X.; Hao, Z.; Zhang, S.; Wu, D.; Sun, H.; Mu, C.; Ren, H.; Wang, G. Poly-PR in C9ORF72-Related Amyotrophic Lateral Sclerosis/Frontotemporal Dementia Causes Neurotoxicity by Clathrin-Dependent Endocytosis. Neurosci. Bull. 2019, 35, 889–900. [Google Scholar] [CrossRef]
Cells 11 02415 g002 550
Figure 2. Model for dysregulated proteostasis in ALS pathogenesis. Impaired proteostasis by ALS-causing mutations, is aggravated by a decline in proteostasis capacity with aging [2], reducing neuronal capacity for handling misfolded proteins. Mutations in genes involved in protein degradation (e.g., VCP, UBQLN2, p62) may impair UPS function directly. C9ORF72-associated dipeptides inhibit the proteasome [92,93]. In addition, excess aggregation of specific mutated proteins (e.g., TDP43, FUS, SOD1, C9ORF72) exhaust and derail UPS function [94,95]. Supersaturated proteins aggregate and further contribute to proteostasis impairment. As a result of this vicious cycle, coaggregation of the neuronal proteome occurs in inclusion bodies.
Figure 2. Model for dysregulated proteostasis in ALS pathogenesis. Impaired proteostasis by ALS-causing mutations, is aggravated by a decline in proteostasis capacity with aging [2], reducing neuronal capacity for handling misfolded proteins. Mutations in genes involved in protein degradation (e.g., VCP, UBQLN2, p62) may impair UPS function directly. C9ORF72-associated dipeptides inhibit the proteasome [92,93]. In addition, excess aggregation of specific mutated proteins (e.g., TDP43, FUS, SOD1, C9ORF72) exhaust and derail UPS function [94,95]. Supersaturated proteins aggregate and further contribute to proteostasis impairment. As a result of this vicious cycle, coaggregation of the neuronal proteome occurs in inclusion bodies.
Cells 11 02415 g002
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Share and Cite

MDPI and ACS Style

Amzallag, E.; Hornstein, E. Crosstalk between Biomolecular Condensates and Proteostasis. Cells 2022, 11, 2415. https://doi.org/10.3390/cells11152415

AMA Style

Amzallag E, Hornstein E. Crosstalk between Biomolecular Condensates and Proteostasis. Cells. 2022; 11(15):2415. https://doi.org/10.3390/cells11152415

Chicago/Turabian Style

Amzallag, Emmanuel, and Eran Hornstein. 2022. "Crosstalk between Biomolecular Condensates and Proteostasis" Cells 11, no. 15: 2415. https://doi.org/10.3390/cells11152415

APA Style

Amzallag, E., & Hornstein, E. (2022). Crosstalk between Biomolecular Condensates and Proteostasis. Cells, 11(15), 2415. https://doi.org/10.3390/cells11152415

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop